Works matching DE "REGENERON Pharmaceuticals Inc."

Results: 40

FDA Decision on Dupilumab for COPD Pushed Back to September 2024.

Published in:

Patient Care (Online), 2024, p. 1

By:

Halsey, Grace

Publication type:

Article

News in brief: Biomedical briefing.

Published in:: Nature Medicine, 2012, v. 18, n. 1, p. 10, doi. 10.1038/nm0112-10
Publication type:: Article

EU Case Reports.

Published in:

Journal of Generic Medicines, 2012, v. 9, n. 3, p. 167, doi. 10.1177/1741134312458519

By:

Burdon, Michael;
Rai, Monika;
Baylos, Pedro Merino;
Seoane, Ramón;
Maxwell, Benedict

Publication type:

Article

Business digest.

Published in:: Chemistry & Industry, 2013, v. 77, n. 5, p. 19
Publication type:: Article

Search for optimal anti-VEGF dosing strategy in AMD continues.

Published in:: Ocular Surgery News, 2009, v. 27, n. 21, p. 19
Publication type:: Article

Eyes on New Product Development.

Published in:

Journal of Ocular Pharmacology & Therapeutics, 2014, v. 30, n. 9, p. 687, doi. 10.1089/jop.2014.1511

By:

Novack, Gary D.

Publication type:

Article

Eyes on New Product Development.

Published in:

Journal of Ocular Pharmacology & Therapeutics, 2014, v. 30, n. 5, p. 371, doi. 10.1089/jop.2014.1507

By:

Novack, Gary D.

Publication type:

Article

Market watch: Upcoming market catalysts in Q3 2013.

Published in:

Nature Reviews Drug Discovery, 2013, v. 12, n. 7, p. 496, doi. 10.1038/nrd4056

By:

Roybal, Dane

Publication type:

Article

Cholesterol-lowering blockbuster candidates speed into Phase III trials.

Published in:

Nature Reviews Drug Discovery, 2012, v. 11, n. 11, p. 817, doi. 10.1038/nrd3879

By:

Mullard, Asher

Publication type:

Article

Patent watch.

Published in:

Nature Reviews Drug Discovery, 2012, v. 11, n. 2, p. 98, doi. 10.1038/nrd3667

By:

Harrison, Charlotte

Publication type:

Article

News in Brief.

Published in:: Nature Reviews Drug Discovery, 2008, v. 7, n. 4, p. 280, doi. 10.1038/nrd2566
Publication type:: Article

Regeneron's Libtayo Surround Program.

Published in:: 2018
Publication type:: Product Review

New biologic.

Published in:: Formulary, 2008, v. 43, n. 4, p. 120
Publication type:: Article

Firms chase diabetic inflammation with anti-IL-1β antibodies.

Published in:

Nature Biotechnology, 2010, v. 28, n. 6, p. 533, doi. 10.1038/nbt0610-533

By:

Sheridan, Cormac

Publication type:

Article

Biotech in a blink.

Published in:

Nature Biotechnology, 2010, v. 28, n. 4, p. 311, doi. 10.1038/nbt0410-311

By:

Garber, Ken

Publication type:

Article

News in brief.

Published in:

Nature Biotechnology, 2007, v. 25, n. 6, p. 613, doi. 10.1038/nbt0607-613

By:

J. K.;
B. H.;
C. S.;
K. S. J.;
A. K.

Publication type:

Article

Lay-offs follow suspension of clinical trials of protein.

Published in:

Nature, 1994, v. 370, n. 6484, p. 6, doi. 10.1038/370006a0

By:

Verrall, Maggie

Publication type:

Article

Drug developers reboot anti-NGF pain programmes.

Published in:

Nature Reviews Drug Discovery, 2015, v. 14, n. 5, p. 297, doi. 10.1038/nrd4612

By:

Mullard, Asher

Publication type:

Article

Trial watch: Atopic dermatitis therapy breakthrough on the horizon?

Published in:

Nature Reviews Drug Discovery, 2014, v. 13, n. 9, p. 645, doi. 10.1038/nrd4414

By:

Cully, Megan

Publication type:

Article

Aflibercept: AVE 0005, AVE 005, AVE0005, VEGF Trap - Regeneron, VEGF Trap (R1R2), VEGF Trap-Eye.

Published in:: Drugs in R&D, 2008, v. 9, n. 4, p. 261
Publication type:: Article

Abnormal Uptake and Air Trapping in Hypersensitivity Pneumonitis Detected on Fluorodeoxyglucose Positron Emission Tomography/Computed Tomography.

Published in:

2019

By:

Yohji Matsusaka;
Ichiro Kawada;
Tadaki Nakahara;
Yu Iwabuchi;
Miho Kawaida;
Masako Matsusaka;
Masahiro Jinzaki;
Matsusaka, Yohji;
Kawada, Ichiro;
Nakahara, Tadaki;
Iwabuchi, Yu;
Kawaida, Miho;
Matsusaka, Masako;
Jinzaki, Masahiro

Publication type:

journal article

Playing with the pieces.

Published in:

Nature, 2003, v. 426, n. 6967, p. 725, doi. 10.1038/426725b

By:

P.M.

Publication type:

Article

Mutual mouse.

Published in:: Nature, 2007, v. 450, n. 7172, p. 935, doi. 10.1038/450935b
Publication type:: Article

Developing and Delivering an Effective eCompliance Training Curriculum - An eLearning Case Study.

Published in:

Journal of Interactive Instruction Development, 2008, v. 21, n. 2, p. 3

By:

Becker, Sandy;
Montanaro, Richard

Publication type:

Article

Responder Threshold for Patient-Oriented Eczema Measure (POEM) and Children's Dermatology Life Quality Index (CDLQI) in Adolescents with Atopic Dermatitis.

Published in:

Dermatology & Therapy, 2019, v. 9, n. 4, p. 799, doi. 10.1007/s13555-019-00333-2

By:

Simpson, Eric L.;
de Bruin-Weller, Marjolein;
Eckert, Laurent;
Whalley, Diane;
Guillemin, Isabelle;
Reaney, Matthew;
Chen, Zhen;
Nelson, Lauren;
Qin, Shanshan;
Bansal, Ashish;
Gadkari, Abhijit

Publication type:

Article

Treatment efficacy in patients with moderate-to-severe atopic dermatitis who switched from dupilumab to abrocitinib in JADE EXTEND, a phase 3 long-term extension study.

Published in:

British Journal of Dermatology, 2024, v. 190, p. ii32, doi. 10.1093/bjd/ljad498.035

By:

Gooderham, Melinda J.;
Weidinger, Stephan;
Simpson, Eric L.;
Deleuran, Mette;
Gold, Linda F. Stein;
Farooqui, Saleem A.;
Biswas, Pinaki;
Chan, Gary;
Güler, Erman;
Koppensteiner, Herwig

Publication type:

Article

434 Efficacy and safety of crisaborole ointment, 2%, in Chinese and Japanese pediatric patients aged 2–17 years with mild-to-moderate atopic dermatitis.

Published in:

British Journal of Dermatology, 2023, v. 188, p. 1, doi. 10.1093/bjd/ljad162.054

By:

Zhang, Jianzhong;
Ma, Lin;
Wang, Shan;
Li, Ping;
Liang, Yunsheng;
Qian, Qiufang;
Cha, Amy;
Canosa, Juliana M;
Zhou, Yangmei;
Chen, Yayuan;
Li, Yinghui

Publication type:

Article

352 Efficacy and safety of abrocitinib in Chinese patients with moderate-to-severe atopic dermatitis: a post-hoc analysis of the JADE REGIMEN phase 3 trial.

Published in:

British Journal of Dermatology, 2023, v. 188, p. ii38, doi. 10.1093/bjd/ljac140.044

By:

Hang Li;
Hao Cheng;
Qianjin Lu;
Wei Lai;
Xiaohua Tao;
Encinas, Gerardo A.;
Vyas, Shefali;
Bo Wang;
Xin Luo;
Shiqi Li

Publication type:

Article

New frontiers in cardiovascular risk reduction: people with diabetes and dyslipidaemia.

Published in:: Diabetes, Obesity & Metabolism, 2019, v. 21, p. 5, doi. 10.1111/dom.13742
Publication type:: Article

Aflibercept gains new approval, recommendation.

Published in:: Optometry Times, 2012, v. 4, n. 10, p. 8
Publication type:: Article

Aflibercept in clinical practice: Evaluation of the first 50 patients treated with antiVEGF trap for age‐related macular degeneration.

Published in:

Acta Ophthalmologica (1755375X), 2012, v. 90, p. 0, doi. 10.1111/j.1755-3768.2012.3662.x

By:

BARBAZETTO, I;
SORENSON, J;
ENGELBERT, M

Publication type:

Article

Mouse mAb patent revoked.

Published in:: Nature Biotechnology, 2014, v. 32, n. 11, p. 1076, doi. 10.1038/nbt1114-1076a
Publication type:: Article

The price of priority review: $67.5 million.

Published in:

Nature Biotechnology, 2014, v. 32, n. 10, p. 973, doi. 10.1038/nbt1014-973

By:

Senior, Melanie

Publication type:

Article

Next-generation AMD drugs to wed blockbusters.

Published in:

Nature Biotechnology, 2014, v. 32, n. 8, p. 701, doi. 10.1038/nbt0814-701

By:

Ratner, Mark

Publication type:

Article

People.

Published in:: Nature Biotechnology, 2014, v. 32, n. 5, p. 498, doi. 10.1038/nbt.2911
Publication type:: Article

Amgen and Regeneron push for a genetic renaissance in drug discovery.

Published in:

Nature Biotechnology, 2014, v. 32, n. 3, p. 208, doi. 10.1038/nbt0314-208

By:

Eisenstein, Michael

Publication type:

Article

Top US universities, institutes for life sciences in 2012.

Published in:

Nature Biotechnology, 2013, v. 31, n. 10, p. 874, doi. 10.1038/nbt.2719

By:

Huggett, Brady

Publication type:

Article

Biologics inch toward cholesterol-lowering market.

Published in:

Nature Biotechnology, 2012, v. 30, n. 4, p. 302, doi. 10.1038/nbt0412-302

By:

Garber, Ken

Publication type:

Article

Eylea approval transforms Regeneron.

Published in:

Nature Biotechnology, 2012, v. 30, n. 1, p. 4, doi. 10.1038/nbt0112-4

By:

Ratner, Mark

Publication type:

Article

Culture and branding are at the heart of Regeneron Pharmaceuticals' growth strategy.

Published in:

Global Business & Organizational Excellence, 2010, v. 29, n. 5, p. 7, doi. 10.1002/joe.20334

By:

Grossman, Ross;
Renton, George

Publication type:

Article